Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferation
Open Access
- 10 December 2012
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 109 (52), 21360-21365
- https://doi.org/10.1073/pnas.1210371110
Abstract
Ezh2 (Enhancer of zeste homolog 2) protein is the enzymatic component of the Polycomb repressive complex 2 (PRC2), which represses gene expression by methylating lysine 27 of histone H3 (H3K27) and regulates cell proliferation and differentiation during embryonic development. Recently, hot-spot mutations of Ezh2 were identified in diffused large B-cell lymphomas and follicular lymphomas. To investigate if tumor growth is dependent on the enzymatic activity of Ezh2, we developed a potent and selective small molecule inhibitor, EI1, which inhibits the enzymatic activity of Ezh2 through direct binding to the enzyme and competing with the methyl group donor S-Adenosyl methionine. EI1-treated cells exhibit genome-wide loss of H3K27 methylation and activation of PRC2 target genes. Furthermore, inhibition of Ezh2 by EI1 in diffused large B-cell lymphomas cells carrying the Y641 mutations results in decreased proliferation, cell cycle arrest, and apoptosis. These results provide strong validation of Ezh2 as a potential therapeutic target for the treatment of cancer.Keywords
This publication has 42 references indexed in Scilit:
- A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cellsNature Chemical Biology, 2012
- Mutation of A677 in histone methyltransferase EZH2 in human B-cell lymphoma promotes hypertrimethylation of histone H3 on lysine 27 (H3K27)Proceedings of the National Academy of Sciences of the United States of America, 2012
- The Polycomb complex PRC2 and its mark in lifeNature, 2011
- EZH2 Y641 mutations in follicular lymphomaLeukemia, 2011
- Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomasProceedings of the National Academy of Sciences of the United States of America, 2010
- Polycomb Mediated Epigenetic Silencing and Replication Timing at the INK4a/ARF Locus during SenescencePLOS ONE, 2009
- Polycomb silencers control cell fate, development and cancerNature Reviews Cancer, 2006
- Polycomb complexes repress developmental regulators in murine embryonic stem cellsNature, 2006
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences of the United States of America, 2005
- The three transforming regions of SV40 T antigen are required for immortalization of primary mouse embryo fibroblasts.1995